These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22325573)

  • 1. Validating imaging biomarkers of cerebral edema in patients with severe ischemic stroke.
    Yoo AJ; Sheth KN; Kimberly WT; Chaudhry ZA; Elm JJ; Jacobson S; Davis SM; Donnan GA; Albers GW; Stern BJ; González RG
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):742-9. PubMed ID: 22325573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke.
    Ma L; Gao PY; Hu QM; Lin Y; Jing LN; Xue J; Chen ZJ; Wang YJ; Liu ML; Cai YF
    Neurol Res; 2011 Jun; 33(5):494-502. PubMed ID: 21669118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.
    Warach S; Pettigrew LC; Dashe JF; Pullicino P; Lefkowitz DM; Sabounjian L; Harnett K; Schwiderski U; Gammans R
    Ann Neurol; 2000 Nov; 48(5):713-22. PubMed ID: 11079534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the association of National Institutes of Health Stroke Scale scores and acute magnetic resonance imaging stroke volume equal for patients with right- and left-hemisphere ischemic stroke?
    Fink JN; Selim MH; Kumar S; Silver B; Linfante I; Caplan LR; Schlaug G
    Stroke; 2002 Apr; 33(4):954-8. PubMed ID: 11935043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke lesion volumes and outcome are not different in hemispheric stroke side treated with intravenous thrombolysis based on magnetic resonance imaging criteria.
    Golsari A; Cheng B; Sobesky J; Schellinger PD; Fiehler J; Gerloff C; Thomalla G
    Stroke; 2015 Apr; 46(4):1004-8. PubMed ID: 25700285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator.
    Nighoghossian N; Hermier M; Adeleine P; Derex L; Dugor JF; Philippeau F; Ylmaz H; Honnorat J; Dardel P; Berthezène Y; Froment JC; Trouillas P
    Stroke; 2003 Feb; 34(2):458-63. PubMed ID: 12574560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Analysis of Markers of Mass Effect after Ischemic Stroke.
    Ostwaldt AC; Battey TWK; Irvine HJ; Campbell BCV; Davis SM; Donnan GA; Kimberly WT
    J Neuroimaging; 2018 Sep; 28(5):530-534. PubMed ID: 29797614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in diffusion-weighted imaging infarct volume predicts neurologic outcome at 90 days: results of the Acute Stroke Accurate Prediction (ASAP) trial serial imaging substudy.
    Barrett KM; Ding YH; Wagner DP; Kallmes DF; Johnston KC;
    Stroke; 2009 Jul; 40(7):2422-7. PubMed ID: 19443798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Deterioration and Early Imaging Changes after Intravenous Tissue Plasminogen Activator Administration in Acute Ischemic Stroke Patients.
    Chou C; Bourekas EC; Slivka A
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1823-1827. PubMed ID: 27133771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diffusion-Weighted Imaging infarct volume and neurologic outcomes after ischemic stroke].
    Attyé A; Boncoeur-Martel MP; Maubon A; Mounayer C; Couratier P; Labrunie A; Le Bas JF
    J Neuroradiol; 2012 May; 39(2):97-103. PubMed ID: 22342940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent Diffusion Coefficient Signal Intensity Ratio Predicts the Effect of Revascularization on Ischemic Cerebral Edema.
    Bevers MB; Battey TWK; Ostwaldt AC; Jahan R; Saver JL; Kimberly WT; Kidwell CS
    Cerebrovasc Dis; 2018; 45(3-4):93-100. PubMed ID: 29533946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining acute diffusion-weighted imaging and mean transmit time lesion volumes with National Institutes of Health Stroke Scale Score improves the prediction of acute stroke outcome.
    Yoo AJ; Barak ER; Copen WA; Kamalian S; Gharai LR; Pervez MA; Schwamm LH; González RG; Schaefer PW
    Stroke; 2010 Aug; 41(8):1728-35. PubMed ID: 20595665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between lesion location and functional outcome after ischemic stroke.
    Yassi N; Churilov L; Campbell BC; Sharma G; Bammer R; Desmond PM; Parsons MW; Albers GW; Donnan GA; Davis SM; ;
    Int J Stroke; 2015 Dec; 10(8):1270-6. PubMed ID: 26045301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lesion volume change after treatment with tissue plasminogen activator can discriminate clinical responders from nonresponders.
    Merino JG; Latour LL; Todd JW; Luby M; Schellinger PD; Kang DW; Warach S
    Stroke; 2007 Nov; 38(11):2919-23. PubMed ID: 17901392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral Blood Volume ASPECTS Is the Best Predictor of Clinical Outcome in Acute Ischemic Stroke: A Retrospective, Combined Semi-Quantitative and Quantitative Assessment.
    Padroni M; Bernardoni A; Tamborino C; Roversi G; Borrelli M; Saletti A; De Vito A; Azzini C; Borgatti L; Marcello O; d'Esterre C; Ceruti S; Casetta I; Lee TY; Fainardi E
    PLoS One; 2016; 11(1):e0147910. PubMed ID: 26824672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperacute-phase computed tomography-diffusion-weighted imaging discrepancy and response to thrombolysis.
    Kawano H; Hirano T; Inatomi Y; Terasaki T; Yonehara T; Uchino M
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):290-6. PubMed ID: 22000527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.
    Alessi MC; Gaudin C; Grosjean P; Martin V; Timsit S; Mahagne MH; Larrue V; Sibon I; Zuber M; Brouns R; Montaner J; Castellanos M; Donazzolo Y; Cho TH; Suissa L; Mechtouff L; Derex L; Suchon P; Mezzapesa A; Nighoghossian N
    Cerebrovasc Dis; 2016; 42(5-6):404-414. PubMed ID: 27387478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.